Rare diseases
Investigational molecules
Locations
Back to Bulgaria5 clinical trials in Byala, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
BulgariaBulgariaBulgariaBulgariaBulgariaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on obesity and cardiovascular safety in overweight individuals. Studies are evaluating novel therapeutic approaches using innovative compounds to assess their impact on major cardiovascular events.
The research aims to establish non-inferiority compared to placebo in preventing adverse cardiovascular events.
Clinical investigations combining chronic kidney disease and hypertension management. The research explores dual-therapy approaches using baxdrostat and dapagliflozin to improve patient outcomes.
These trials focus on preventing kidney failure and reducing cardiovascular mortality risks.
Advanced studies in Type 2 Diabetes treatment optimization, examining combination therapies with gliclazide MR and dapagliflozin. Research targets improved glycemic control in patients with inadequate response to current treatments.
The focus is on achieving superior HbA1c reduction through innovative treatment combinations.
Innovative research on hypertriglyceridemia management, including studies of plozasiran in both standard and severe cases. These trials aim to effectively reduce fasting serum triglyceride levels.
The studies evaluate novel therapeutic approaches for different severity levels of triglyceride disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
